中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
GNE-477抑制剂 |
GNE-477 |
1032754-81-6 |
C21H28N8O3S2 |
|
GNE-0877抑制剂 |
2-methyl-2-(3-methyl-4-((4-(methylamino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)-1H-pyrazol-1-yl)propanenitrile |
1374828-69-9 |
C14H16F3N7 |
|
GMD-C16-二聚体 |
GMD-C16-dimer |
1043569-41-0 |
C72H108N6O16 |
|
GM1-五糖 |
LS-tetrasaccharide a |
52659-37-7 |
C37H62N2O29 |
|
GLYX13抑制剂 |
Glyx-13 |
117928-94-6 |
C18H31N5O6 |
|
GLPG0187,一种广谱的INTEGRIN受体拮抗剂,具有抗肿瘤活性 |
L-Alanine, 3-((2,5-dimethyl-6-(4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)-1-piperidinyl)-4-pyrimidinyl)amino)-N-((4-methoxyphenyl)sulfonyl) |
1320346-97-1 |
C29H37N7O5S |
|
GLPG-0634 中间体 |
N-(5-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide |
1142943-96-1 |
C10H9BrN4O |
|
GJ103游离 |
2-((4-(3-methoxyphenyl)-5-(pyridin-2-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid |
1459687-89-8 |
C16H14N4O3S |
|
GJ-103钠盐 |
sodium 2-((4-(3-methoxyphenyl)-5-(pyridin-2-yl)-4H-1,2,4-triazol-3-yl)thio)acetate |
1459687-96-7 |
C16H13N4O3S*Na |
|
GENZ-644282抑制剂 |
2,3-dimethoxy-12-(2-(methylamino)ethyl)[1,3]dioxolo[4',5':4,5]-benzo[1,2-h]benzo[c][1,6]naphthyridin-13(12H)-one |
529488-28-6 |
C22H21N3O5 |
|
GDC-0349; N-Ethyl-N'-[4-[5,6,7,8-四氢-4-[(3S)-3-甲基-4-吗啉基]-7-(3-氧杂环丁基)吡啶并[3,4-d]嘧啶-2-基]苯基]脲 |
(S)-1-ethyl-3-(4-(4-(3-methylmorpholino)-7-(oxetan-3-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-2-yl)phenyl)urea |
1207360-89-1 |
C24H32N6O3 |
|
GD-6肽 |
7,8,9-Trihydroxy-7,8,9,10-tetrahydrobenzo(a)pyrene-10-sulfonate |
124443-16-9 |
C20H16O6S |
|
GC-R2醚化物 |
N,N'-bis(2,6-diisopropylphenyl)-1,6,7,12-tetraphenoxy perylene-3,4:9,10-tetracarboxylic acid diimide |
123174-58-3 |
C72H58N2O8 |
|
GAMMA-谷氨酸 |
7-γ-L-glutamyl-4-methylcoumarinylamide |
72669-53-5 |
C15H16N2O5 |
|
GAMMA-[4-(三氟甲基)苯氧基]苯丙胺草酸盐 |
3-(p-trifluoromethylphenoxy)-3-phenylpropylamine oxalate |
107674-50-0 |
C2H2O4*C16H16F3NO |
|
GALUNISERTIB中间体 |
4-(2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carbonitrile |
924898-13-5 |
C22H17N5 |
|
G9A和PRC2抑制剂(BRD9539) |
2-benzamido-1-(3-phenylpropyl)-1H-1,3-benzodiazole-5-carboxylic acid |
1374601-41-8 |
C24H21N3O3 |
|
G2聚糖 |
G2 Glycan |
71496-53-2 |
C62H104N4O46 |
|
G2-多肽 |
G2-peptide |
361443-81-4 |
C90H155N13O54 |
|
G-碘丁腈 |
4-iodobutyronitrile |
6727-73-7 |
C4H6IN |
|
G-418 硫酸盐 |
geneticin sulfate |
108321-42-2 |
C20H40N4O10*H2O4S |
|
Fumars辵remonoEthylesterMagnesiumSalz |
|
83918-60-9 |
C6H8MgO4 |
|
Fragransin A2; 4,4'-[(2R,3R,4R,5R)-四氢-3,4-二甲基-2,5-呋喃基]双[2-甲氧基苯酚] |
(+)-fragransin A2 |
112652-46-7 |
C20H24O5 |
|
Fr900098单钠盐 |
3-(N-acetyl-N-hydroxyamino)-propylphosphonic acid monosodium salt |
73226-73-0 |
C5H11NO5P*Na |
|
Forxiga; 丙二醇达格列嗪水合物 |
dapagliflozin (S) propylene glycol hydrate |
960404-48-2 |
C3H8O2*C21H25ClO6*H2O |
|
Formyl-L-缬氨酸 |
N-formyl-L-valine |
4289-97-8 |
C6H11NO3 |
|
Foliamenthoic acid; (E,E)-8-羟基-2,6-二甲基-2,6-辛二烯酸 |
8-hydroxy-2,6-dimethyl-(2E,6E)-octadienoic acid |
26187-80-4 |
C10H16O3 |
|
Fmoc-(S)-3-氨基-3-(3-吡啶基)丙酸 |
(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(pyridin-3-yl)propanoic acid |
507472-06-2 |
C23H20N2O4 |
|
Fmoc-(S)-3-氨基-3-(3,4-二甲氧基苯基)丙酸 |
(3S)-3-(3,4-dimethoxyphenyl)-3-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic Acid |
501015-37-8 |
C26H25NO6 |
|
Fmoc-(S)-3-氨基-3-(2-萘基)丙酸 |
Fmoc-(S)-3-Amino-3-(2-naphthyl)-propionic acid |
507472-11-9 |
C28H23NO4 |
|
Fmoc-(S)-3-氨基-3-(2-呋喃基)丙酸 |
Fmoc-(S)-3-amino-3-(2-furyl)-propionic acid |
1217741-88-2 |
C22H19NO5 |
|
Fmoc-(S)-3-噻吩基甘氨酸 |
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-(thiophen-3-yl)acetic acid |
1217706-09-6 |
C21H17NO4S |
|
Fmoc-(R)-3-氨基-4-(2,4,5-三氟苯基)丁酸 |
(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic acid |
1217818-53-5 |
C25H20F3NO4 |
|
Fmoc-(R)-3-氨基-3-(3-氰基苯基)丙酸 |
Fmoc-(R)-3-Amino-3-(3-cyano-phenyl)-propionic acid |
517905-91-8 |
C25H20N2O4 |
|
Fmoc-(R)-3-氨基-3-(3,5-二甲氧基苯基)丙酸 |
Fmoc-(R)-3-Amino-3-(3,5-dimethoxy-phenyl)-propionic acid |
511272-41-6 |
C26H25NO6 |
|
Fmoc-(R)-3-氨基-3-(3,4-二甲氧基苯基)丙酸 |
Fmoc-(R)-3-Amino-3-(3,4-dimethoxy-phenyl)-propionic acid |
511272-40-5 |
C26H25NO6 |
|
Fmoc-(R)-3-氨基-3-(2-羟苯基)丙酸 |
(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-hydroxyphenyl)propanoic acid |
511272-34-7 |
C24H21NO5 |
|
Fmoc-(R)-3-氨基-3-(2,3-二甲氧基苯基)丙酸 |
Fmoc-(R)-3-Amino-3-(2,3-dimethoxy-phenyl)-propionic acid |
511272-39-2 |
C26H25NO6 |
|
Fmoc-(R)-2-(氨基甲基)-4-甲基戊酸 |
Fmoc-(R)-β<sup>2</sup>hLeu-OH |
1018899-99-4 |
C22H25NO4 |
|
Fmoc-(R)-2-甲氧基苯基甘氨酸 |
(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-(2-methoxyphenyl)acetic acid |
1217838-25-9 |
C24H21NO5 |
|
Fmoc-(3S,6S,9R)-2-氧代-3-氨基-7-硫杂-1-氮杂双环[4.3.0]壬烷-9-羧酸 |
(3R,6S,8aS)-6-Amino-6-{[(9H-fluoren-9-yl)methoxy]carbonyl}-5-oxohexahydro-5H-[1,3]thiazolo[3,2-a]pyridine-3-carboxylic acid |
204326-07-8 |
C23H22N2O5S |
|
Fmoc-(3S,4S)-4-氨基-1-氧基-1,2,2,6,6-四甲基哌啶-3-羧酸 |
(3R,4S)-4-(9H-fluoren-9-ylmethoxycarbonylamino)-1-hydroxy-2,2,6,6-tetramethylpiperidine-3-carboxylic acid |
583827-12-7 |
C25H30N2O5 |
|
Fmoc-(3R,4R)-4-氨基-1-氧基-1,2,2,6,6-四甲基哌啶-3-羧酸 |
Fmoc-(3R,4R)-4-amino-1-oxyl-2,2,6,6-tetramethylpiperidine-3-carboxylic Acid |
583827-13-8 |
C25H30N2O5 |
|
Fmoc-肌氨酸五氟苯酯 |
N-[N-(fluoren-9-ylmethoxycarbonyl)-N-methylglycyl]pentafluorophenyl ester |
159631-29-5 |
C24H16F5NO4 |
|
Fmoc-缬氨醇 |
2-[(S)-(fluoren-9-ylmethoxycarbonyl)amino]-3-methylbutan-1-ol |
160885-98-3 |
C20H23NO3 |
|
Fmoc-甘氨酸-D2 |
Fmoc-α-d2-glycine |
284665-11-8 |
C17H15NO4 |
|
Fmoc-甘氨酸 |
N-(fluoren-9-ylmethoxycarbonyl)glycine |
29022-11-5 |
C17H15NO4 |
|
Fmoc-环戊基-D-Gly-OH |
(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-cyclopentylacetic acid |
136555-16-3 |
C22H23NO4 |
|
Fmoc-环亮氨酸 |
1-(9H-fluoren-9-ylmethoxycarbonylamino)-cyclopentanecarboxylic acid |
117322-30-2 |
C21H21NO4 |
|
Fmoc-氨基丙氨酸 |
2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)malonic acid |
296261-32-0 |
C18H15NO6 |
|